MedTrace Logo

Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG

NCT02606240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-08-08

No results posted yet for this study

Summary

This pilot observational study will assess changes in pH /PaO2 /PaCO2, Respiratory Rate and device CO2 clearance in the first 24 hours of Extracorporeal CO2 removal (ECCO2R) following tidal volume (Vt), and plateau pressure reduction in patients with mild to moderate ARDS.

Conditions

  • Acute Respiratory Distress Syndrome

Interventions

DEVICE

CO2 removal with PRISMALUNG in ARDS

Observational study of patients with mild to moderate Acute Respiratory Distress Syndrome (ARDS) submitted to Extracorporeal CO2 removal (ECCO2R) with the PRISMALUNG device to allow ultraprotective mechanical ventilation with tidal volume reduction (from 6 to 4 ml/kg, predicted body weight) and plateau pressure reduction from 28-30 to 23-25 cmH2O.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • University Hospital, Montpellier

    collaborator OTHER

  • Groupe Hospitalier Pitie-Salpetriere

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02606240 on ClinicalTrials.gov